Aceso Life Science Group Limited has issued a proxy circular for its annual general meeting (AGM), set for 10:30 a.m. on 16 September 2026 at 25/F, Shui On Centre, Wanchai, Hong Kong. Shareholders are invited to vote on the following ordinary resolutions:

• Financial Statements: Acceptance of the audited consolidated results and the reports of the directors and independent auditors for the financial year ended 31 March 2026.

• Board Composition and Remuneration: – Re-election of executive director Mr Fok Chi Tak. – Re-election of independent non-executive director Mr Mak Yiu Tong. – Authorisation for the board to determine directors’ remuneration.

• Auditor Appointment: Re-appointment of Moore CPA Limited as independent auditors and authorisation for the board to fix their remuneration.

• Share Capital Mandates: – A general mandate allowing the board to allot, issue or deal with new shares up to 20% of the company’s issued share capital as at the date of the AGM. – Authorisation for the company to repurchase its own shares not exceeding 10% of the issued share capital on the same date. – Extension of the 20% issuance mandate by adding the number of shares repurchased under the 10% buy-back mandate.

Shareholders may appoint the AGM chairman or another proxy to vote on their behalf. Completed proxy forms, together with any required authorisations, must reach Computershare Hong Kong Investor Services Limited no later than 48 hours before the meeting. All resolutions will be decided by poll.